DE602004023509D1 - Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels - Google Patents

Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels

Info

Publication number
DE602004023509D1
DE602004023509D1 DE602004023509T DE602004023509T DE602004023509D1 DE 602004023509 D1 DE602004023509 D1 DE 602004023509D1 DE 602004023509 T DE602004023509 T DE 602004023509T DE 602004023509 T DE602004023509 T DE 602004023509T DE 602004023509 D1 DE602004023509 D1 DE 602004023509D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
agent
short
acting sedative
sedative hypnosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004023509T
Other languages
English (en)
Inventor
Thomas E Jenkins
Jennifer Bolton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innoviva Inc
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of DE602004023509D1 publication Critical patent/DE602004023509D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
DE602004023509T 2003-07-23 2004-07-21 Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels Active DE602004023509D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48955903P 2003-07-23 2003-07-23
PCT/US2004/023275 WO2005009420A2 (en) 2003-07-23 2004-07-21 Pharmaceutical compositions of short-acting sedative hypnotic agent

Publications (1)

Publication Number Publication Date
DE602004023509D1 true DE602004023509D1 (de) 2009-11-19

Family

ID=34102897

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004023509T Active DE602004023509D1 (de) 2003-07-23 2004-07-21 Pharmazeutische zusammensetzungen eines kurzwirkenden sedativen hypnosemittels

Country Status (12)

Country Link
US (2) US7790766B2 (de)
EP (1) EP1648413B1 (de)
AT (1) ATE444734T1 (de)
CY (1) CY1109657T1 (de)
DE (1) DE602004023509D1 (de)
DK (1) DK1648413T3 (de)
ES (1) ES2332514T3 (de)
HK (1) HK1090841A1 (de)
PL (1) PL1648413T3 (de)
PT (1) PT1648413E (de)
SI (1) SI1648413T1 (de)
WO (1) WO2005009420A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8546453B2 (en) * 2003-08-14 2013-10-01 Rensheng Zhang Propofol compositions and methods for reducing pain associated with propofol injection
EA200802166A1 (ru) * 2006-04-20 2009-06-30 Эмджен Инк. Стабильная фармацевтическая композиция с защитным действием от раздражения (варианты), способ ее получения и способ лечения кальций-миметиком с ее помощью
RU2012144777A (ru) * 2010-05-13 2014-06-20 Астразенека Аб Инъекционная эмульсия седативного снотворного агента
CN105106115A (zh) * 2015-10-10 2015-12-02 北京蓝丹医药科技有限公司 一种稳定的丙泮尼地脂肪乳

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1134981B (de) 1960-05-06 1962-08-23 Bayer Ag Verfahren zur Herstellung von N-substituierten 3-Methoxy-4-carbamidomethoxyphenylessigsaeurealkyl- und alkenylestern
US3086978A (en) * 1960-05-06 1963-04-23 Bayer Ag 3-methoxy-4-carbamidomethoxy-phenylacetic acid esters
NL284933A (de) * 1961-10-31
NL286944A (de) 1961-12-20
CH432494A (de) 1964-01-10 1967-03-31 Geigy Ag J R Verfahren zur Herstellung neuer Aryloxyessigsäureamide
US3510559A (en) * 1964-01-10 1970-05-05 Geigy Chem Corp 2-alkoxyphenoxy-acetamides as anesthetics agents
DE1249851B (de) * 1964-02-11 1967-09-14 J R Geigy A G Basel (Schweiz) Morel Ariesheim (Schweiz) j Verfahren zur Herstellung neuer Phenoxyessigsäure amide
US3511877A (en) * 1964-02-11 1970-05-12 Geigy Chem Corp Phenoxyacetic acid diethylamides
DE1518819B1 (de) 1965-04-03 1969-12-04 Basf Ag Loesungsvermittler fuer pharmazeutische Zwecke
US4798846A (en) * 1974-03-28 1989-01-17 Imperial Chemical Industries Plc Pharmaceutical compositions
GB1571395A (en) 1976-07-12 1980-07-16 Delmar Chem Substituted phenyl acetic acid esters
JPS5699440A (en) * 1980-01-11 1981-08-10 Ube Ind Ltd Preparation of 3-alkoxy-4-hydroxyphenylacetic acid
DE3168925D1 (en) * 1980-12-23 1985-03-28 Koehler Chemie Dr Franz Protective solution for heart and kidney, and manufacturing process
JPS6038343A (ja) 1983-08-11 1985-02-27 Mitsubishi Petrochem Co Ltd フエニル酢酸誘導体の製造方法
DE3339236A1 (de) * 1983-10-28 1985-05-09 Bayer Ag Arzneimittelzubereitung
US4918092A (en) * 1983-12-21 1990-04-17 Merck Frosst Canada, Inc. Leukotriene antagonists
IT1204778B (it) * 1986-02-04 1989-03-10 Mazzarella Basilio Formulazioni farmaceutiche iniettabili di principi attivi ad attivita' anestetica generale
US5092838A (en) * 1989-11-30 1992-03-03 Baxter International Inc. Histidine buffered peritoneal dialysis solution
US6140394A (en) * 1990-02-23 2000-10-31 Tomoegawa Paper Co. Method and apparatus of suspension polymerization
US5242944A (en) * 1991-06-20 1993-09-07 Korea Research Institute Of Chemical Technology Phenylacetamide derivatives and pharmaceutical compositions thereof
US20020173547A1 (en) * 1994-03-22 2002-11-21 Jones Christopher Buchan Pharmaceuticals compositions
GB9405593D0 (en) * 1994-03-22 1994-05-11 Zeneca Ltd Pharmaceutical compositions
ZA962214B (en) 1995-04-10 1996-10-07 Farmarc Nederland Bv Pharmaceutical composition
US6281175B1 (en) * 1997-09-23 2001-08-28 Scimed Life Systems, Inc. Medical emulsion for lubrication and delivery of drugs
PE20000264A1 (es) * 1998-02-10 2000-04-11 Gensia Sicor Inc Composicion de propofol que contiene sulfito
US6028108A (en) * 1998-10-22 2000-02-22 America Home Products Corporation Propofol composition comprising pentetate
US6140374A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6140373A (en) * 1998-10-23 2000-10-31 Abbott Laboratories Propofol composition
US6177477B1 (en) * 1999-03-24 2001-01-23 American Home Products Corporation Propofol formulation containing TRIS
US6726919B2 (en) * 2000-06-16 2004-04-27 Rtp Pharma, Inc. Injectable dispersion of propofol
US6887866B2 (en) * 2002-01-25 2005-05-03 Theravance, Inc. Short-acting sedative hypnotic agents for anesthesia and sedation

Also Published As

Publication number Publication date
US7981931B2 (en) 2011-07-19
HK1090841A1 (en) 2007-01-05
SI1648413T1 (sl) 2010-01-29
EP1648413B1 (de) 2009-10-07
WO2005009420A3 (en) 2005-03-03
EP1648413A2 (de) 2006-04-26
CY1109657T1 (el) 2014-08-13
PL1648413T3 (pl) 2010-03-31
WO2005009420A2 (en) 2005-02-03
US20100076079A1 (en) 2010-03-25
US20050020674A1 (en) 2005-01-27
ES2332514T3 (es) 2010-02-08
DK1648413T3 (da) 2010-01-11
US7790766B2 (en) 2010-09-07
ATE444734T1 (de) 2009-10-15
PT1648413E (pt) 2009-12-28

Similar Documents

Publication Publication Date Title
CY1118179T1 (el) Φαρμακευτικη συνθεση
ES2524458T3 (es) DNasa para el tratamiento de la subfertilidad masculina
CY1122336T1 (el) Eνωσεις πυρρολιου ως αναστολεις πρωτεϊνικων κινασων εrκ και φαρμακευτικες συνθεσεις που περιεχουν αυτες τις ενωσεις
HK1075039A1 (en) Short-acting sedative hypnotic agents for anesthesia and sedation
DE602004031462D1 (de) Allgemein lineare brauseform von fentanyl zur oralen anwendung und verfahren zur verabreichung
BRPI0617165A2 (pt) Compostos inibidores mek, composições farmacêuticas que os contem e métodos de uso dos mesmos
CY1111197T1 (el) Tριαζολες χρησιμες ως αναστολεις πρετεϊνικων κινασων
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
TW200722421A (en) Azole derivatives as inhibitors of lipases and phospholipases
EA200801945A1 (ru) Пирролотриазинанилиновые пролекарственные соединения, полезные в качестве ингибиторов киназы
EA200700312A1 (ru) Композиции для доставки лекарственных средств с высокой водорастворимостью
CY1108700T1 (el) Συνθεσεις απελευθερωσης φαρμακου εστερα αλφα-υδροξυ οξεος και μεθοδοι χρησης
IL181700A0 (en) Quinazoline derivatives and pharmaceutical compositions containing the same
ECSP088296A (es) Compuestos terapéuticos
UY30460A1 (es) Compuestos terapéuticos
TW200730513A (en) Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
ATE492271T1 (de) Verfahren zur herstellung eines hydroxystilben- haltigen drogenextraktes
ECSP045493A (es) Nuevas composiciones farmacéuticas que contienen flibanserina polimorfo a
BRPI0415053B8 (pt) inibidor de glicoproteína-p, método para preparar o mesmo e composição farmacêutica que compreende o mesmo
ATE363840T1 (de) Capsaicinoid enthaltende pharmazeutische zusammensetzung zur oralen verabreichung
MY142792A (en) Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases
MY146444A (en) Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases
CY1109657T1 (el) Φαρμακευτικες συνθεσεις ηρεμιστικου υπνωτικου μεσου ταχειας δρασης
MY146803A (en) Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
UY27753A1 (es) Formulación farmacéutica que comprende melatonina.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition